Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's drug pipeline, vaccines and more.
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
Pfizer Inc. is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.
Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...
Pfizer CEO Albert Bourla has revealed that he recently dined with health secretary nominee and vaccine skeptic Robert F.
Speaking to the Financial Times, Albert Bourla pointed out that during two days of grilling from US senators last week, Kennedy, Donald Trump’s nominee for US health secretary, “was very ...
Kennedy Jr. In a Tuesday earnings call, CEO Albert Bourla said Trump had introduced him to Kennedy, a longtime vaccine critic, and the duo ended up having dinner together. Bourla did not specify ...
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...
Trump administration to eliminate thousands of federal health jobs; Major drugmakers plan to meet with Trump; New York versus Louisiana abortion pills fight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results